Jun 17:  In the U.S. Court of Appeals, D.C. Circuit, Case No. 10-1142. On Petition for Writ of  Mandamus to the Food and Drug  Administration. The appeal concerns whether this court or the  district court has jurisdiction over matters relating to  a citizen petition filed pursuant to Food and Drug Administration (FDA) regulations promulgated under the  Food, Drug, and  Cosmetic Act (the Act) , 21 U.S.C. §§ 301 et seq.    
     The Appeals Court  explains that because its citizen petition to revoke regulations permitting  Bisphenol A (BPA) to be used as a food additive, see, e.g, 21 C.F.R. §  177.1555; id. § 177.1595, has been pending since October 21, 2008, the Natural Resources  Defense Council (NRDC) seeks what amounts to a writ of mandamus directing the  FDA to issue a final decision on its petition. The Appeals Court rules, "We hold  that exclusive jurisdiction over citizen petitions lies in the district court,  and accordingly we dismiss the petition." The Appeals Court says further,  "Accordingly, because the NRDC cannot show that jurisdiction over its citizen  petition lies exclusively in this court, or that all final FDA action on its  petition would be directly and exclusively reviewable  in this court, we dismiss the petition for lack of  jurisdiction."
  
     In further  explanation, the Appeals Court said, "during oral argument, counsel for the NRDC suggested that section 10.30(e)(1) of the regulations,  providing that the FDA 'shall . . . rule  upon each petition . . . taking into consideration . . . time requirements established by statute,'  requires the FDA to comply with the  statutory timeline in section 409(c)(2) of  the Act, and thereby establishes that the citizen petition process is governed by the requirements of  section 409 generally. Oral Arg. Recording  at 3:02-3:23. The NRDC referred to section  10.30(e) in its Petition at 8, but only in  the context of listing the three possible responses by the FDA to a citizen petition. This was insufficient to put the  FDA on notice of the argument presented  during oral argument. Ordinarily  this would mean that the argument is forfeited. Cf.  U.S. v. Southerland, 486 F.3d  1355, 1360 (D.C. Cir. 2007). Inasmuch as the NRDC's petition is filed as an original  proceeding in this court and the issue  goes to our jurisdiction, however, we reach the merits. See Shays v. FEC, 528 F.3d 914,  92223 (D.C. Cir. 2008).  The FDA correctly argued in its response that section  10.30(e)(1) does nothing more than make the statutory  deadlines one of several factors that the FDA must consider and weigh in its discretion. This provision simply  highlights the difference between the food additive  petition review process, which is subject to the  statutory timeline, and review of a citizen petition  established by regulation, which treats the timeline as  a guideline for the FDA to consider and allows for a  "tentative response" by the FDA. The NRDC's reliance on  section 10.30(e) is thus insufficient to support its position that section 409 applies generally to its citizen  petition."